2.79
Precedente Chiudi:
$2.75
Aprire:
$2.73
Volume 24 ore:
743.06K
Relative Volume:
0.51
Capitalizzazione di mercato:
$1.04B
Reddito:
$159.54M
Utile/perdita netta:
$5.06M
Rapporto P/E:
-634.09
EPS:
-0.0044
Flusso di cassa netto:
$26.19M
1 W Prestazione:
+1.45%
1M Prestazione:
+4.49%
6M Prestazione:
+10.28%
1 anno Prestazione:
+36.10%
Cronos Group Inc Stock (CRON) Company Profile
Nome
Cronos Group Inc
Settore
Telefono
(416) 504-0004
Indirizzo
4491 CONCESSION RD 12, STAYNER, ON
Compare CRON vs TAK, HLN, TEVA, ZTS, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
CRON
Cronos Group Inc
|
2.79 | 1.03B | 159.54M | 5.06M | 26.19M | -0.0044 |
|
TAK
Takeda Pharmaceutical Co Adr
|
17.15 | 53.43B | 29.91B | 1.30B | 3.49B | 0.4056 |
|
HLN
Haleon Plc Adr
|
10.10 | 44.52B | 14.54B | 2.22B | 2.58B | 0.4871 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.03 | 37.52B | 17.53B | 1.58B | 444.18M | 1.3457 |
|
ZTS
Zoetis Inc
|
76.56 | 32.24B | 9.51B | 2.64B | 2.14B | 6.0361 |
|
UTHR
United Therapeutics Corp
|
535.67 | 22.46B | 3.17B | 1.29B | 1.01B | 27.09 |
Cronos Group Inc Stock (CRON) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-27 | Iniziato | Canaccord Genuity | Buy |
| 2022-11-02 | Iniziato | Bernstein | Mkt Perform |
| 2022-07-28 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2022-05-11 | Aggiornamento | CIBC | Neutral → Sector Outperform |
| 2022-03-22 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2022-01-27 | Aggiornamento | Jefferies | Underperform → Hold |
| 2021-11-18 | Ripresa | BofA Securities | Underperform |
| 2021-04-28 | Ripresa | BofA Securities | Underperform |
| 2021-02-22 | Downgrade | CIBC | Sector Outperform → Neutral |
| 2020-06-24 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2020-04-27 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2020-04-14 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2020-04-02 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2020-03-31 | Downgrade | Canaccord Genuity | Hold → Sell |
| 2020-03-04 | Aggiornamento | MKM Partners | Neutral → Buy |
| 2020-03-03 | Downgrade | Stifel | Buy → Hold |
| 2019-10-18 | Aggiornamento | Stifel | Hold → Buy |
| 2019-09-20 | Iniziato | MKM Partners | Neutral |
| 2019-09-05 | Aggiornamento | BMO Capital Markets | Underperform → Market Perform |
| 2019-08-13 | Iniziato | Piper Jaffray | Overweight |
| 2019-08-09 | Aggiornamento | Canaccord Genuity | Sell → Hold |
| 2019-06-28 | Iniziato | Consumer Edge Research | Equal Weight |
| 2019-06-06 | Iniziato | Stifel | Hold |
| 2019-06-05 | Aggiornamento | BofA/Merrill | Underperform → Buy |
| 2019-04-17 | Iniziato | BofA/Merrill | Underperform |
| 2019-03-27 | Downgrade | Canaccord Genuity | Hold → Sell |
| 2019-02-25 | Iniziato | Jefferies | Underperform |
| 2019-01-18 | Iniziato | CIBC | Sector Outperform |
Mostra tutto
Cronos Group Inc Borsa (CRON) Ultime notizie
Top Cannabis Stocks To ResearchJuly 18th - MarketBeat
Cronos Group Inc. stock rises Friday, outperforms market - MarketWatch
Cronos Group stock trades steady as cannabis earnings and cash position shape outlook - ad-hoc-news.de
Cronos Group to hold Q2 2026 earnings call on A... - Pluang
Cronos Group - Baystreet.ca
Cronos Group to hold Q2FY26 earnings call on August 6 - scanx.trade
Cronos Group Inc. to Hold 2026 Second Quarter Earnings Conference Call on August 6, 2026 - The Manila Times
Cronos Group management to discuss Q2 results on Aug. 6 - Stock Titan
Cannabis Stocks To Add to Your WatchlistJuly 12th - MarketBeat
Promising Cannabis Stocks To Add to Your WatchlistJuly 11th - MarketBeat
Cronos Group Inc. stock falls Friday, underperforms market - MarketWatch
Why Are These Top 3 TSX Stocks in the Market Spotlight? - Kalkine Media
Cronos Group Inc. stock rises Thursday, still underperforms market - MarketWatch
Cannabis Stocks To Follow TodayJuly 9th - MarketBeat
Cronos Group Inc outlines cannabis strategy as industry evolves - ad-hoc-news.de
Cronos Group Inc. stock falls Monday, underperforms market - MarketWatch
Why Is Cronos Group (NASDAQ:CRON) Extending CanAdelaar Deal? - Kalkine Media
Cronos Group Holds Steady at $2.86 as Cannabis Sector Awaits CatalystsProtective Put - dars.gov.et
Cronos Group refines its cannabis strategy as investors weigh long-term growth prospects - ad-hoc-news.de
Cronos Group Inc.'s Equity Buyback announced on May 8, 2025, has expired. - marketscreener.com
Cronos appoints ATB Cormark as new broker for C... - Pluang
Cronos Group changes broker for share repurchase program - Investing.com
Cronos Group changes broker for share repurchase program By Investing.com - Investing.com India
Cronos Group Inc. stock falls Tuesday, underperforms market - MarketWatch
Cronos Announces Appointment of ATB Cormark as its Broker for Share Repurchases in Canada - GlobeNewswire
Cronos Group (CRON) adds director Darren Chester Broughton as reporting insider on Form 3 - Stock Titan
TSX Penny Stocks To Watch In June 2026 - simplywall.st
CRONCronos Group Inc Volatility & Greeks - Finviz
Cronos Group Inc. stock rises Monday, still underperforms market - MarketWatch
Price to earnings forward of Cronos Group Inc – TSX:CRON - TradingView
Cronos Group (CRON) price target increased by 10.71% to 3.79 - MSN
CRON strengthens global footprint: Is the cannabis stock worth buying? - MSN
CRON Forecast — Price Target — Prediction for 2027 - TradingView
Cronos Group Inc Actuals & Estimates (TSX:CRON) - TradingView
Cronos Group Inc Actuals & Estimates (FWB:7CI) - TradingView
7CI Forecast — Price Target — Prediction for 2027 - TradingView
Cronos Group Inc Actuals & Estimates (NEO:CRON) - TradingView
CRON Strengthens Global Footprint: Is the Cannabis Stock Worth Buying? - Yahoo Finance
Cronos Group Inc. Announces Results of 2026 Annual Meeting of Shareholders - Sahm
Cronos Shareholders Approve Directors, Say-on-Pay and Auditor - The Globe and Mail
Cronos Group Inc. stock rises Tuesday, outperforms market - MarketWatch
Cronos Group shareholders approve board slate and auditor at annual meeting By Investing.com - Investing.com Australia
Form 8K CRONOS GROUP INC. For: 22 June By Investing.com - Investing.com India
Cronos Group Inc. (CRON) Announces 2026 Annual Meeting Results and Key SEC Filing Details - Minichart
Cronos Group shareholders approve board slate and auditor at annual meeting - Investing.com
Cronos Group shareholders re-elect directors and approve executive pay at 2026 annual meeting - Pluang
Cronos Group (NASDAQ: CRON) holders back pay and auditor at 2026 meeting - Stock Titan
Cronos Group shareholders approve all resolutions at 2026 meeting - scanx.trade
Cronos Group StockAnalyst views and long-term cannabis strategy - AD HOC NEWS
Why Is Cronos Group Inc. (TSX:CRON) Rising After Buyback in S&P/TSX Composite Index? - Kalkine Media
Should Cronos Group’s Expanded US$50 Million Buyback Shape Capital Allocation Views For Cronos (TSX:CRON) Investors? - Yahoo Finance
Cronos Group Inc Azioni (CRON) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Cronos Group Inc Azioni (CRON) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Wagner Adam | See remarks |
May 12 '26 |
Option Exercise |
0.00 |
10,367 |
0 |
103,987 |
| Buggy Shannon | See Remarks |
May 12 '26 |
Option Exercise |
0.00 |
20,622 |
0 |
187,501 |
| Kenost Jared Matthew | See Remarks |
May 12 '26 |
Option Exercise |
0.00 |
9,412 |
0 |
46,675 |
| Weigensberg Arye | See Remarks |
May 10 '26 |
Option Exercise |
0.00 |
3,118 |
0 |
211,555 |
| Wagner Adam | See remarks |
May 10 '26 |
Option Exercise |
0.00 |
20,470 |
0 |
93,620 |
| Kenost Jared Matthew | See Remarks |
May 10 '26 |
Option Exercise |
0.00 |
12,649 |
0 |
39,141 |
| Shlimak Anna | See Remarks |
Mar 19 '26 |
Option Exercise |
0.00 |
28,429 |
0 |
368,362 |
| Doucet Terrence Gregory Joseph | See Remarks |
Mar 15 '26 |
Option Exercise |
0.00 |
23,897 |
0 |
117,466 |
| Weigensberg Arye | See Remarks |
Mar 15 '26 |
Option Exercise |
0.00 |
24,236 |
0 |
208,437 |
| GORENSTEIN MICHAEL RYAN | See remarks below |
Mar 15 '26 |
Option Exercise |
0.00 |
324,540 |
0 |
13,340,723 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):